Banks' Q4 earnings to drop

The banking sector, which had seen good set of numbers in the third quarter, is likely to report subdued earnings in the fourth quarter of 2008-09 due to slowdown in credit growth and pressure on......

Domestic drug makers immune to slowdown

At a time when various industries have been hit due to the current economic slowdown, the domestic pharmaceutical market registered a value growth of 14.4 per cent in January and 9.9 per cent in......

Imitrex delay: Ranbaxy may lose up to Rs 300 cr

Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore (Rs 3 billion) due to delay in receiving approval from the US Food and Drug Administration (FDA)......

Wockhardt to raise Rs 500 crore

Drug major Wockhardt, which is trying to raise funds for meeting payments to its foreign currency convertible bond holders,said on Friday the company was planning to raise Rs 500 crore (Rs 5......